HMOX1 and periodontitis: Furthermore, investigating the effects of HO-1 targeted drugs related to oxidative stress diseases on the development and progression of periodontitis may mitigate the risk of medication duplication in patients suffering from systemic oxidative stress diseases concomitant with periodontitis, thereby facilitating more precise therapeutic interventions for optimal efficacy and prognosis.